For over 120 years, Bayer has been researching and developing innovative medications and new therapeutic approaches that help make a difference to people’s lives.
Artificial intelligence will help drive unprecedented productivity improvements and better outcomes across the value chain from drug discovery to delivery.
READ MORE
INNOVATION
Finding New Options for Cardiovascular Patients
A non-communicable disease, such as cardiovascular disease, more commonly affects adults or older people2.
READ MORE
TRENDS
Artificial Intelligence - When we Suddenly Know What we Don’t Know
Machines can now create new knowledge rather than just data outputs.